Leukemia Clinical Trials in Georgia

Cancer Type = Leukemia

Cancer Type = Leukemia

There are currently 32 active Leukemia clinical trials in Georgia.
1.
A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
Cancer Type
Leukemia
NCI ID
NCT01503632
Protocol IDs
ACCL1033
COG-ACCL1033
CDR0000721559
NCI-2012-00105
Treatment Sites (1)
Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
Howard M. Katzenstein, MD
404-785-0853
2.
A Phase 1 / 2 Multicenter Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Subjects With Relapsed / Refractory Chronic Lymphocytic Leukemia
Cancer Type
Leukemia, Lymphoma
NCI ID
NCT03624036
Protocol IDs
KTE-C19-108
NCI-2018-02958
2018-001923-38
3.
A Phase 1 / 2 Study of Oral LOXO-305 in Patients With Previously Treated Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (CLL / SLL) or Non-Hodgkin's Lymphoma (NHL)
Cancer Type
Leukemia, Lymphoma, Non-Hodgkin Lymphoma
NCI ID
NCT03740529
Protocol IDs
LOXO-BTK-18001
NCI-2019-02015
5.
A Phase 1 Multiple Ascending Dose Study of DS-3201b in Subjects With Lymphomas
Cancer Type
Leukemia, Lymphoma, Non-Hodgkin Lymphoma
NCI ID
NCT02732275
Protocol IDs
DS3201-A-J101
NCI-2019-00366
6.
NCORP Trial
A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb®14045 in Patients With CD123-Expressing Hematologic Malignancies
Cancer Type
Leukemia, Lymphoma, Myelodysplastic Syndromes (MDS), Skin Cancer (Non-Melanoma)
NCI ID
NCT02730312
Protocol IDs
XmAb14045-01
NCI-2016-00916
7.
A Phase 1 Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies
Cancer Type
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Leukemia, Lymphoma, Neuroblastoma
NCI ID
NCT03236857
Protocol IDs
M13-833
NCI-2017-02027
2017-000439-14
9.
A Phase 1, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of Ascending Doses of AZD5991 in Subjects With Relapsed or Refractory Haematologic Malignancies
Cancer Type
Hodgkin Lymphoma, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma, Skin Cancer (Non-Melanoma), Unknown Primary
NCI ID
NCT03218683
Protocol IDs
D6910C00001
NCI-2017-01390
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
Scott Edelman
404-778-5180
12.
A Phase 2, Open-Label, Monotherapy, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement
Cancer Type
Eye Cancer, Leukemia
NCI ID
NCT03011372
Protocol IDs
INCB 54828-203
NCI-2017-00141
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
Scott Edelman
404-778-5180
13.
NCORP Trial
A Phase 2, Randomized, Biomarker-driven, Clinical Study on Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Cancer Type
Leukemia
NCI ID
NCT02520011
Protocol IDs
TPI-ALV-201
NCI-2015-02082
16.
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
Cancer Type
Leukemia, Myelodysplastic Syndromes (MDS)
NCI ID
NCT02396134
Protocol IDs
13494
NCI-2015-00283
118814
121375
119250
118207
18.
NCORP Trial
A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults
Cancer Type
Acute Lymphoblastic Leukemia, Leukemia
NCI ID
NCT02003222
Protocol IDs
NCI-2013-02229
ECOG-E1910
E1910
U10CA021115
U10CA180820
24.
Assessing Financial Difficulty in Patients with Blood Cancers
Cancer Type
Leukemia
NCI ID
NCT03870633
Protocol IDs
A231602CD
A231602CD
NCI-2018-01708
A231602CD
25.
NCORP Trial
Assessing the Impact of a Simplified Patient Care Strategy to Decrease Early Deaths In Acute Promyelocytic Leukemia (APL) By Maintaining A Database
Cancer Type
Leukemia
NCI ID
NCT02309333
Protocol IDs
IRB00067432
WINSHIP2488-13
EA9131
Treatment Sites (2)
Georgia CORE

 

Hearts and Minds Dedicated to Improving Cancer Care

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.